Psoriatic in Medical News

Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions

... up to 30 percent of people with psoriasis develop psoriatic arthritis, which causes pain, swelling and ... with mild psoriasis are just as likely to develop psoriatic arthritis as those with moderate or severe forms ... Foundation urges people with psoriasis and psoriatic arthritis to work with their dermatologists to ...

Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn

... of Americans who are affected by psoriasis and psoriatic arthritis. Our mission is to find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating ... of increased research funding for psoriasis and psoriatic arthritis. We also work to educate psoriasis ...

Psoriasis Cure Now Welcomes Institute of Medicine Report Urging 'Comparative Effectiveness' Research on Psoriasis, But Worries About Risk of Rationing

... of Medicine (IOM) for including psoriasis and psoriatic arthritis among its Top 100 health topics ... for treating inflammatory diseases including psoriatic arthritis among its top ("First Quartile") ... for including treatments for psoriasis and psoriatic arthritis among its priority research areas, as ...

New Source of Information on Psoriasis Medications

... and resources for people with psoriasis and psoriatic arthritis. Links to the National Psoriasis ... of Americans who are affected by psoriasis and psoriatic arthritis. Our mission is to find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating ...

Driven by Sales of Enbrel, Remicade and Humira, spondyloarthropathies Drug Market Grew to Nearly $2 Billion in 2008

... the seronegative SpAs - ankylosing spondylitis, psoriatic arthritis, and reactive arthritis - and ushered ... Drug Administration (FDA) for the treatment of psoriatic arthritis and ankylosing spondylitis. ... market in 2008 for ankylosing spondylitis and psoriatic arthritis was approximately $1.8 billion, the ...

SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... to severely active rheumatoid arthritis, active psoriatic arthritis and active ankylosing spondylitis. ... treatment option. Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis are chronic ... range of patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis who had ...

New drug shows promising results for psoriatic arthritis

... psoriatic arthritis affects about 11 percent of patients ... that induce inflammation, improve the symptoms of psoriatic arthritis. Golimumab is a new human monoclonal ... to be completed with a biologic agent to treat psoriatic arthritis and the first placebo-controlled study ...

LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital

... Krafsur struggles with severe psoriasis and psoriatic arthritis, which occurs in up to 30 percent of ... stiffness and swelling in and around the joints. psoriatic arthritis can be debilitating if left untreated. ... is dedicated to finding a cure for psoriasis and psoriatic arthritis through the creation of Alyssa's Fund, ...

Drug Reduces Inflammatory Arthritis Symptoms, Lesions

... -- The drug ustekinumab shows promise against psoriatic arthritis (PA), according to a study that ... is efficacious and safe for treatment of active psoriatic arthritis. Our study is one of the first to ... ustekinumab efficacy and safety for treatment of psoriatic arthritis," wrote Dr. Alice Gottlieb, of the ...

MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks

... uses in the treatment of ankylosing spondylitis, psoriatic arthritis and pediatric Crohn's disease will ... (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), ... Crohn's disease, ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis for a long time, ...

National Psoriasis Foundation Seeks 10,000 Americans to Support Psoriasis Research for World Psoriasis Day

... and build unity among the psoriasis and psoriatic arthritis community. "Over the past decade, the ... that will help people with psoriasis and psoriatic arthritis receive the treatment they need," said ... to 30 percent of people with psoriasis develop psoriatic arthritis, an inflammatory disease which causes ...

National Psoriasis Foundation Releases 2008 Study Results

... The survey of 426 individuals with psoriasis and psoriatic arthritis also revealed that their disease ... and mental impact psoriasis and psoriatic arthritis can have on one's health," said Randy ... the need to continue raising awareness about psoriatic diseases and ensure the public knows ...

After Fits and Starts, New Hope for Psoriasis Patients

... 30 percent of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and ... mature and fall off the body in 28 to 30 days. A psoriatic skin cell takes just three to four days to mature ... and three of those five are approved for psoriatic arthritis. Biologics are effective, and they also ...

Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... adults with active forms of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Golimumab, ... factors may contribute to the disease. About psoriatic Arthritis psoriatic arthritis is a chronic inflammatory arthropathy ...

Dermatologists Release Psoriasis Care Guidelines

... the management of mild to severe psoriasis and psoriatic arthritis released by the American Academy of ... immune responses involved with psoriasis and psoriatic arthritis. About 6 million to 7 million ... psoriasis, and between 300,000 and 750,000 have psoriatic arthritis. The new guidelines, based on an ...

American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis and Psoriatic Arthritis

... of care for the management of psoriasis and psoriatic arthritis based on an extensive analysis of the ... are affected by psoriasis, and the presence of psoriatic arthritis in the general U.S. population has been ... Academy of Dermatology, the new psoriasis and psoriatic guidelines present the latest recommendations for ...

New In-Depth Informative Website Launched for People With Psoriasis and Psoriatic Arthritis

... 1st of May 2008, UK charity, the Psoriasis and psoriatic Arthritis Alliance (PAPAA) is launching its new ... Source of Information for Psoriasis and psoriatic Arthritis. PAPAA is providing an up-to-date ... people real input in the content. Psoriasis and psoriatic arthritis can both be confusing and demoralising; ...

Researchers Identify New Genetic Links to Psoriasis

... one of which links the skin condition and psoriatic arthritis to other autoimmune disorders. The ... that increases their risk of psoriasis and psoriatic arthritis." Psoriasis, in which the body's ... Up to 30 percent of sufferers may also develop psoriatic arthritis, an often excruciatingly painful and ...

New findings show Enbrel significantly reduced levels of C-reactive protein

... to severe plaque psoriasis patients without psoriatic arthritis (n=501) demonstrated: Patients had ... investigator, co-director of the Psoriasis and psoriatic Arthritis Center of New York University Medical ... of body fat, in people with psoriasis without psoriatic arthritis. Notably, obesity is common among ...

National Psoriasis Foundation Marks World Psoriasis Day With Call to Support Psoriasis Legislation

... to raise public awareness about psoriasis and psoriatic arthritis and the seriousness of these diseases. ... educate our national leaders about psoriasis and psoriatic arthritis," said Psoriasis Foundation President ... of millions of Americans with psoriasis and/or psoriatic arthritis, and their families. The Psoriasis ...

M.D. Anderson-led team reports possible key to autoimmune disease

... previously showed that pDC activation in psoriatic skin drives the development of human psoriasis ... with release of self-DNA and pDC activation in psoriatic skin leading to disease formation. They lacked a ... they identified LL37 as the key ingredient in psoriatic tissue that activates the dendritic cells. The ...

Empowerment Program Gets Patients on the PATH to Managing the Physical and Emotional Effects of Psoriatic Arthritis

... from painful and, at times, embarrassing, psoriatic arthritis, have a new resource. Today, the ... officially launched the 2007 PATH program -- psoriatic Arthritis Total approach to Health -- with an ... body" relief and support to people living with psoriatic arthritis -- a disease characterized by pain, ...

America's Next Top Model Steps up for Psoriasis Awareness

... walks to generate awareness about psoriasis and psoriatic arthritis while raising funds for psoriasis ... 30 percent of people with psoriasis may develop psoriatic arthritis, which causes pain, stiffness ... quality of life of people who have psoriasis and psoriatic arthritis. Through education and advocacy, we ...

Schering-Plough Reports Financial Results for 2009 First Quarter

... rheumatoid arthritis, early rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, pediatric Crohn's disease ... the first once-monthly, subcutaneous therapy for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, marking the first approval in the ...

Rockefeller University's Center for Clinical and Translational Science funds 18 new pilot studies

... T cells that protect the skin from extracellular bacteria in juvenile psoriatic arthritis. Mina Pastagia, M.D., instructor in clinical investigation, ... cells from atherosclerotic plaques compared to dendritic cells from psoriatic skin lesions and to perform gene expression analysis on cell subsets of ...

Indigo Ointment Benefits Psoriasis Patients

... in traditional Chinese medicine. The patients applied the ointment to a psoriatic plaque on one side of their body (usually the arm, elbow, leg or knee) and applied a non-medicated ointment to a psoriatic plaque on the other side of their body. The patients' skin plaques were ...

Genetic disorder sheds light on enzyme's role in bone metabolism

... a 55-year-old female patient with pycnodysostosis who also developed psoriatic arthritis. Since the patient lacked cathepsin K due to her condition, ... protect her from the bone erosions in the hands and feet normally seen in psoriatic arthritis. However, she did in fact develop extensive erosions and ...

LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis

... 1999. The drug treats psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, sarcoidosis and ulcerative colitis. The ... arthritis, moderate to severe polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis and plaque psoriasis. In addition to the ...

Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies

... in ankylosing spondylitis (AS), rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients with a previously inadequate response to ... to an anti-TNF in the past reached ACR20, and 26% achieved ACR50. psoriatic arthritis 42% of PsA patients who had previously undergone anti-TNF ...

Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis

... antibody approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), Crohn.s disease and plaque ... of structural damage and improving physical function in patients with psoriatic arthritis. HUMIRA can be used alone or in combination with MTX or other ...

Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions

... more severe cases of psoriasis appear to have an increased incidence of psoriatic arthritis, cardiovascular disease, hypertension, diabetes, cancer, ... the quality of life of millions of Americans with psoriasis and/or psoriatic arthritis, and their families. The Psoriasis Foundation focuses on ...

Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers

... ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. ENBREL is ...

Avidas(TM) Pharmaceuticals and LaRon(TM) Pharma Inc. Announce Co-Promotion Agreement

... disease which affects the skin and joints. It commonly causes red scaly patches to appear on the skin. The scaly patches caused by psoriasis, called psoriatic plaques, are areas of inflammation and excessive skin production. Skin rapidly accumulates at these sites and takes on a silvery white appearance. ...

Diagnosis of arthritis 5 years earlier in childless women compared to those with children

... June 2009: Nulliparous women (those who have not given birth to children) are diagnosed with chronic arthritides (including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) an average of 5.2 years before parous women (those who have given birth to children), according to a new ...

American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications

... the guidelines of care for psoriasis, with three previously published sections focusing on general recommendations for the treatment of psoriasis and psoriatic arthritis, as well as the use of biologics and topical therapies. "While in recent years biologics have changed the treatment of psoriasis, ...

Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs

... 50 million Americans suffer from diseases of the immune system, and there are approximately 10 million people living with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and plaque psoriasis. Infectious Diseases ...

Chlamydia may play role in a type of arthritis

... clinical features such as inflammatory back pain and inflammation at sites where tendons attach to bone. It includes ankylosing spondylitis (AS), psoriatic arthritis, inflammatory bowel-disease-related arthritis, reactive arthritis (ReA) and undifferentiated spondylarthritides (uSpA). Since Chlamydia ...

New Report by BioTrends Research Group to Highlight the Launch of SIMPONI(R) (golimumab)

... once-monthly subcutaneous anti-TNF-alpha therapy, SIMPONI is approved for the treatment of moderately to severely active rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis. The product will be available in two dosing delivery forms: the SIMPONI SmartJect autoinjector and a ...

Medarex to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... market SIMPONI(TM) (golimumab, also known as CNTO 148) as a once-monthly subcutaneous treatment for adults with active forms of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. SIMPONI is a new, human anti-tumor necrosis factor (TNF) monoclonal antibody that was generated by ...

Psoriasis Drug Raptiva Pulled From U.S. Market

... experts noted. PML is caused by a virus. Psoriasis is an autoimmune disease that usually shows up on the skin and can also manifest as psoriatic arthritis, according to the National Psoriasis Association. Genentech said Wednesday that it was working with Merck Serono, its licensee outside ...